Bottom line
What does IDNA hold?
IDNA held 61 positions as of Jul 31, 2026. Its largest holding is BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares at 10.39% of the fund, and the top 10 positions add up to 49.5%. By asset type it is 96% stocks, 10% cash & short-term funds, 4% other.
Updated Sep 23, 2026
IDNA top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY |
Cash & short-term funds | 10.39% | $19.8M |
| 2 | Bayer Aktiengesellschaft BAYER AG |
Stocks | 4.81% | $9.2M |
| 3 | Twist Bioscience Corp TWIST BIOSCIENCE CORP |
Stocks | 4.79% | $9.1M |
| 4 | Revolution Medicines, Inc. REVOLUTION MEDICINES INC |
Stocks | 4.55% | $8.7M |
| 5 | Regeneron Pharmaceuticals, Inc. REGENERON PHARMACEUTICALS INC |
Stocks | 4.35% | $8.3M |
| 6 | Genmab A/s GENMAB A S |
Stocks | 4.23% | $8.1M |
| 7 | Incyte Corporation | Stocks | 4.23% | $8.1M |
| 8 | Moderna, Inc. MODERNA INC |
Stocks | 4.19% | $8.0M |
| 9 | Takeda Pharmaceutical Company Limited TAKEDA PHARMACEUTICAL CO LTD |
Stocks | 4.05% | $7.7M |
| 10 | Merck & Co., Inc. MERCK CO INC |
Stocks | 3.91% | $7.5M |
| 11 | Vertex Pharmaceuticals Incorporated VERTEX PHARMACEUTICALS INC |
Stocks | 3.87% | $7.4M |
| 12 | Roche Holding AG ROCHE HOLDING AG |
Stocks | 3.85% | $7.3M |
| 13 | Ipsen Sa | Stocks | 3.84% | $7.3M |
| 14 | BioNTech SE BIONTECH SE |
Other | 3.73% | $7.1M |
| 15 | Exelixis, Inc. EXELIXIS INC |
Stocks | 3.65% | $7.0M |
| 16 | Gsk Plc | Stocks | 3.63% | $6.9M |
| 17 | Sanofi Sa SANOFI |
Stocks | 3.46% | $6.6M |
| 18 | IDEAYA Biosciences Inc IDEAYA BIOSCIENCES INC |
Stocks | 3.36% | $6.4M |
| 19 | Immunitybio Inc IMMUNITYBIO INC |
Stocks | 3.07% | $5.9M |
| 20 | Arcus Biosciences, Inc. ARCUS BIOSCIENCES INC |
Stocks | 2.68% | $5.1M |
| 21 | Caris Life Sciences, Inc. CARIS LIFE SCIENCES INC |
Stocks | 2.19% | $4.2M |
| 22 | Ono Pharmaceutical Co., Ltd. ONO PHARMACEUTICAL CO LTD |
Stocks | 1.91% | $3.7M |
| 23 | Iovance Biotherapeutics Inc IOVANCE BIOTHERAPEUTICS INC |
Stocks | 1.80% | $3.4M |
| 24 | Nuvation Bio Inc. NUVATION BIO INC |
Stocks | 1.78% | $3.4M |
| 25 | CRISPR Therapeutics AG CRISPR THERAPEUTICS AG |
Stocks | 1.57% | $3.0M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026